Drug CategoryDrugIHD Dosing

Administration Timing Around HD Session

AntibioticsCeftazidime1-2g IV QHDAdminister Post-HD

Molecular Weight    (Da)

Excreted Unchanged (%)Normal Half-Life (Hours)ESRD Half-Life (Hours)Plasma Protein Binding (%)Volume of Distribution (L/kg)Dialytic Plasma Clearance (ml/min)% Dialyzed
54760-851.213-255-240.18-0.3160-15541-81 (high flux)


  • Aronoff GR, Bennett WM, Berns JS, Brier ME, Kasbekar N, Mueller BA, et al. Drug Prescribing in Renal Failure. Philadelphia: American College of Physicians;2007.
  • DrugBank [Online]. 2012 Apr 12 [cited 2012 May 6]; Available from: URL: http://www.drugbank.ca/drugs/DB00438
  • Heintz B, Matzke G, Dager W. Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis. Pharmacotherapy 2009; 29(5), 562-77.
  • Leroy A, Leguy F, Borsa F, Spencer G, Fillastre J. Pharmacokinetics of Ceftazidime in Normal and Uremic Subjects. Microbiology 1984; 25(5).
  • Matzke G. Status of Hemodialysis of Drugs in 2002. Journal of Pharmacy Practice 2002; 15(5), 405-418.
  • Van Dalen R, Vree T, Baars A, Termond E. Dosage adjustment for ceftazidime in patients with impaired renal function. European journal of clinical pharmacology 1986; 30(5), 597-605.